Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.050 | 0.600 | 5 | 2012 | 2018 | ||||
Carcinoma of lung
|
1204 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.050 | 0.800 | 5 | 2015 | 2019 | ||||
Colorectal Carcinoma
|
1962 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.050 | 0.800 | 5 | 2012 | 2018 | ||||
Malignant neoplasm of breast
|
3417 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.050 | 0.600 | 5 | 2012 | 2018 | ||||
Malignant neoplasm of lung
|
1142 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.050 | 0.800 | 5 | 2015 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.050 | 0.800 | 5 | 2015 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.040 | 0.750 | 4 | 2017 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.040 | 0.750 | 4 | 2017 | 2018 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.030 | 0.667 | 3 | 2012 | 2018 | ||||
Papillary thyroid carcinoma
|
204 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||
Head and Neck Carcinoma
|
118 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.020 | 1.000 | 2 | 2017 | 2018 | ||||
Liver carcinoma
|
942 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.020 | 0.500 | 2 | 2014 | 2016 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.020 | 1.000 | 2 | 2017 | 2018 | ||||
Nasopharyngeal carcinoma
|
320 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||
Neoplasms
|
1644 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||
Benign neoplasm of thyroid gland
|
4 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Cancer of Digestive System
|
15 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1 | 2018 | 2018 | |||||
Cirrhosis
|
110 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Epstein-Barr Virus Infections
|
72 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
HER2-positive carcinoma of breast
|
26 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Ischemic stroke
|
704 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1 | 2019 | 2019 | |||||
Liver Cirrhosis
|
189 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Locally Recurrent Malignant Neoplasm
|
1 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Malignant neoplasm of stomach
|
615 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Mucocutaneous Lymph Node Syndrome
|
195 | 0.641 | 0.520 | 10 | 100975021 | mature miRNA variant | C/G | snv | 0.27 | 0.27 | 0.010 | 1.000 | 1 | 2019 | 2019 |